What is she best known for?
The fields of study she is best known for:
- Virus
- Gene
- Internal medicine
The scientist’s investigation covers issues in Virology, Influenza A virus, Virus, Oseltamivir and Neuraminidase.
Her research in Virology intersects with topics in T cell and Pandemic influenza.
The study incorporates disciplines such as Viral evolution, Hemagglutinin, Outbreak, H5N1 genetic structure and Cytotoxic T cell in addition to Influenza A virus.
All of her Virus and Influenza A virus subtype H5N1 and Viral load investigations are sub-components of the entire Virus study.
Her work deals with themes such as Viral replication, Zanamivir, Drug resistance and Pandemic, which intersect with Oseltamivir.
Her study in Zanamivir is interdisciplinary in nature, drawing from both Peramivir and Neuraminidase inhibitor.
Her most cited work include:
- The global circulation of seasonal influenza A (H3N2) viruses. (580 citations)
- Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. (373 citations)
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents (325 citations)
What are the main themes of her work throughout her whole career to date?
Aeron C. Hurt focuses on Virology, Virus, Influenza A virus, Neuraminidase and Oseltamivir.
Her Virology study integrates concerns from other disciplines, such as Zanamivir and Neuraminidase inhibitor.
Her Virus research includes elements of Transmission and Epitope.
Aeron C. Hurt combines subjects such as Viral evolution, Hemagglutinin, Viral disease, Outbreak and H5N1 genetic structure with her study of Influenza A virus.
Her Neuraminidase research is multidisciplinary, incorporating perspectives in Antiviral drug, Mutation, Viral replication and Microbiology.
Her Oseltamivir study combines topics from a wide range of disciplines, such as Viral load, Pandemic, Nitazoxanide, Peramivir and Drug resistance.
She most often published in these fields:
- Virology (88.04%)
- Virus (56.94%)
- Influenza A virus (44.98%)
What were the highlights of her more recent work (between 2019-2021)?
- Virus (56.94%)
- Virology (88.04%)
- Transmission (13.40%)
In recent papers she was focusing on the following fields of study:
Aeron C. Hurt mostly deals with Virus, Virology, Transmission, Influenza A virus and Oseltamivir.
Her Virus research incorporates elements of Viral evolution, Hospitalized patients, CD8, Immune system and Disease.
Aeron C. Hurt has researched Virology in several fields, including Residue, Pyrosequencing and Amino acid.
Her biological study spans a wide range of topics, including Juvenile, Host and Viral replication.
Her research integrates issues of Neuraminidase inhibitor, Neuraminidase, Zanamivir, Combination therapy and Viral shedding in her study of Oseltamivir.
Her research investigates the connection with Neuraminidase and areas like Peramivir which intersect with concerns in Laninamivir.
Between 2019 and 2021, her most popular works were:
- Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018. (30 citations)
- Sustained RNA virome diversity in Antarctic penguins and their ticks. (12 citations)
- The impact of climate and antigenic evolution on seasonal influenza virus epidemics in Australia. (8 citations)
In her most recent research, the most cited papers focused on:
- Virus
- Gene
- Internal medicine
Her primary scientific interests are in Virus, Virology, Influenza A virus, Oseltamivir and Neuraminidase.
Her studies deal with areas such as Microbiome, Zoology, RNA, Viral evolution and Tick as well as Virus.
She works on Virology which deals in particular with Antiviral resistance.
She interconnects Transmission and Neuraminidase inhibitor in the investigation of issues within Influenza A virus.
Her research in Oseltamivir tackles topics such as Nitazoxanide which are related to areas like Combination therapy, Ribavirin, Influenza treatment and Favipiravir.
Aeron C. Hurt works mostly in the field of Neuraminidase, limiting it down to topics relating to Peramivir and, in certain cases, Laninamivir, Drug resistance and Zanamivir, as a part of the same area of interest.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
